The use of driving impairing medicines: A European survey

European Journal of Clinical Pharmacology

Volumn 65, Issue 11, 2009, Pages 1139-1147

  Ravera, Silvia ^a   Hummel, Sylvia A ^a   Stolk, Pieter ^b   Heerdink, Rob E ^b   De Jong Van Den Berg, Lolkje T W ^a   De Gier, Johan J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Bias; Driving impairing medicines; Drug utilization; European survey

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; BEZITRAMIDE; FENTANYL; HYDROMORPHONE; HYPNOTIC SEDATIVE AGENT; LEVACETYLMETHADOL; LEVOCETIRIZINE; METHADONE; NEUROLEPTIC AGENT; OPIATE; OXYCODONE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DRIVING ABILITY; DRUG UTILIZATION; EUROPE; HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; AUTOMOBILE DRIVING; DRUG UTILIZATION; EUROPE; HUMANS; PSYCHOTROPIC DRUGS;

EID: 70350217964     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0695-7     Document Type: Article

References (34)

1. Hedqvist Petersen E (2000) Report on the communication from the Commission to the Council, the European Parliament, the Economic and Social Committee and the Committee of the Regions on "Priorities in EU road safety-progress report and ranking of actions" [COM (2000) 125-C5-0248/2000-2000/2136 (COS)]. Adopted by Parliament on 18 January 2001. Strasbourg
2. Raes E, van den Neste T, Verstraete AG (2008) EMCDDA INSIGHTS: drug use, impaired driving and traffic accidents. EMCDDA, Lisbon. Available at: http://www.emcdda.europa.eu/publications/insights/driving. Accessed 25 May 2009
3. European Commission (2001) White Paper European Transport Policy for 2010: time to decide. Office for Official Publications of the European Communities, Luxembourg
4. http://www.druid-project.eu. Accessed 15 Sept 2008
5. http://www.eurodurg.com. Accessed 15 Sept 2008
6. http://www.whocc.no/atcddd, The purpose of the ATC/DDD system. Accessed 15 Sept 2008
7. JM Walsh JJ de Gier AS Christopherson AG Verstraete 2004 Drugs and driving Traffic Inj Prev 5 241 253 10.1080/15389580490465292 15276925 (Pubitemid 39049928)
8. F Barbone AD McMahon PG Davey AD Morris IC Reid DG McDevitt TM MacDonald 1998 Association of road-traffic accidents with benzodiazepine use Lancet 352 1331 1336 10.1016/S0140-6736(98)04087-2 1:STN:280:DyaK1M%2Fhslamtw%3D%3D 9802269 (Pubitemid 28510912)
9. MC del Río J Gómez M Sancho FJ Alvarez 2002 Alcohol, illicit drugs and medicinal drugs in fatally injured drivers in Spain between 1991 and 2000 Forensic Sci Int 127 63 70 10.1016/S0379-0738(02)00116-0 (Pubitemid 34722761)
10. Hindmarch I (1986) The effect of psychoactive drugs on car handling and related psychomotor ability: a review. In: O'Hanlon JF, de Gier JJ (eds) Drugs and driving. Taylor and Francis Group, London, pp 71-82
11. KLL Movig MPM Mathijssen PHA Nagel T van Egmond JJ de Gier HGM Leufkens ACG Egberts 2004 Psychoactive substance use and the risk of motor vehicle accidents Accident Anal Prev 36 631 636 10.1016/S0001-4575(03)00084-8 1:STN:280:DC%2BD2c7ptlCitA%3D%3D
12. Moskowitz H (2004) Antihistamine and driving related behavior: a review of the evidence for impairment. Report number DOT HS 809 073. Available at: http://www.nhtsa.dot.gov/people/injury/research. Accessed 15 Sept 2008
13. Council Directive 91/439/EEC of 29 July 1991 on driving licences. Official Journal L. 237, 24/08/1991 1-24
14. http://www.whocc.no/atcddd. Alterations in DDDs. Accessed 15 Sept 2008
15. SE Bruce RG Vasile RM Goisman C Salzman M Spencer JT Machan MB Keller 2003 Are Benzodiazepines Still the Medication of Choice for Patients With Panic Disorder With or Without Agoraphobia? Am J Psychiatry 160 1432 1438 10.1176/appi.ajp.160.8.1432 12900305 (Pubitemid 41070918)
16. SH Kennedy RW Lam NL Cohen AV Ravindran 2001 Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments Can J Psychiatry 46 Suppl 1 38S 58S 11441771
17. C Allgulander B Bandelow E Hollander SA Montgomery DJ Nutt A Osaka MH Pollack DJ Stein RP Swinson 2003 WCA recommendations for the long-term treatment of generalized anxiety disorder CNS Spectr 8 Suppl 1 53 61 14767398 (Pubitemid 38419781)
18. GKV-Modernisierungsgesetz (GMG) 2004 BGBl. I 2190 of 14 November 2003. Available at: http://www.buzer.de/gesetz/7332/index.htm. Accessed 3 Sept 2008
19. J Fuerst M Kocmur 2003 Use of psychiatric drugs in Slovenia in comparison to Scandinavian countries Pharmacoepidemiol Drug Saf 12 399 403 10.1002/pds.826 (Pubitemid 36903376)
20. World Health Organization (2004) The world medicine situation. Available at: http://apps.who.int/medicinedocs/en/d/Js6160e/10.html. Accessed 26 May 2009
21. N Divac DL Toševski D Babić D Djurić M Prostran R Samardžić 2006 Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004 Pharmacoepidemiol Drug Saf 15 835 838 10.1002/pds.1316 16958148 (Pubitemid 44762715)
22. C Furtado I Teixeira 2006 Utilização de benzodiazepinas em Portugal continental (1999-2003) Acta Med Port 19 239 246 17234086 (Pubitemid 44605705)
23. http://www.emea.europa.eu/pdfs/human/press/pus/877601en.pdf. Accessed 15 Sep 2008
24. M Rønning HS Blix H Strøm E Skovlund M Andersen RH Vander Stichele 2003 Problems in collecting comparable national drug use data in Europe: the example of antibacterials Eu J Clin Pharmacol 58 843 849
25. RH Vander Stichele MM Elsevier M Ferech S Blot H Goossens ESAC Project Group 2004 European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach Br J Clin Pharmacol 58 419 428 10.1111/j.1365-2125.2004.02164.x 1:STN:280:DC%2BD2cvmsVGnug%3D%3D 15373935 (Pubitemid 39312466)
26. http://www.euromedstat.cnr.it/default.asp. Accessed 26 May 2009
27. R Cooperstock P Parnell 1982 Research on psychotropic drug use. A review of findings and methods Soc Sci Med 16 1179 1196 10.1016/0277-9536(82)90143-5 1:STN:280:DyaL383nslemtw%3D%3D 7112165 (Pubitemid 12013989)
28. World Health Organization (1970) Consumption of drugs. Report on a Symposium convened by the Regional Office for Europe of the WHO. WHO, Copenhagen
29. K Hamunen P Laitinen-Parkkonen P Paakkari H Breivik T Gordh NH Jensen E Kalso 2002 What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 12 705 715 10.1016/j.ejpain.2007.10.012
30. K Ojaniemi T Lintonen AO Impinen PM Lillsunde AI Ostamo 2009 Trends in driving under the influence of drugs: A register-based study of DUID suspects during 1977-2007 Accident Anal Prev 41 191 196 10.1016/j.aap.2008.10.011
31. JG Bramness S Skurtveit J Mørland 2002 Clinical impairment of benzodiazepines - relation between benzodiazepine concentrations and impairment in apprenended drivers Drug Alcohol Depend 68 131 141 10.1016/S0376-8716(02) 00188-6 1:CAS:528:DC%2BD38XntVeitbY%3D 12234642 (Pubitemid 35251884)
32. H Gjerde PT Normann BS Pettersen T Assum M Aldrin U Johansen L Kristoffersen E Oiestad AS Christophersen J Mørland 2008 Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: A roadside survey Accident Anal Prev 40 1765 1772 10.1016/j.aap.2008.06.015
33. S Skurtveit AS Christophersen J Mørland 1995 Driving under the influence of benzodiazepines: Provincial differences in sale are reflected in drivers suspected of driving under the influence of a drug Tidsskr Norske Laegeforen 115 Suppl 2 200 203 1:STN:280:DyaK2M7lvFSqug%3D%3D
34. EMCDDA (2006) Annual report 2006: the state of the drugs problem in Europe 2006. EMCDDA, Lisbon